ScoutQuest29 Sep 2026
Platinum Industries544134JV deal update

Subsidiary Rivadu Lifesciences signs exclusive India sale/purchase agreement with Korea's CAREGEN for "Korglutide"

Subsidiary Rivadu Lifesciences Pvt Ltd has entered an exclusive Sale/Purchase Agreement for India with CAREGEN Co., Ltd., Korea, dated 28 September 2026.

Agreement Date
28 September 2026
Partner
CAREGEN Co., Ltd., Korea
Product Brand
Korglutide
Product Category
health functional food finished products
Territory
India (exclusive partnership)

What was announced

Platinum Industries Limited informed the exchanges that its subsidiary, Rivadu Lifesciences Private Limited, has entered into an exclusive Sale/Purchase Agreement for India with CAREGEN Co., Ltd., Korea, on 28 September 2026.

The agreement relates to CAREGEN's health functional food finished products marketed under the brand name Korglutide.

Significant terms disclosed

Other details

How to read this

This is a commercial tie-up at the subsidiary level that gives the group exclusive rights to sell a Korean partner's health functional food products in India, with the possibility of local manufacturing later. It signals a step into a product line outside the company's traditional chemicals base. Investors may watch for future updates on volumes, revenue contribution and any manufacturing plans, since the agreement's financial terms and expected business size are not quantified here.

Source: BSE · 29 Sep 2026

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.